{
"id":"mk19_a_np_q093",
"number":93,
"bookId":"np",
"correctAnswer":"E",
"title":"Question 93",
"stimulus":[
{
"type":"p",
"hlId":"e5248e",
"children":[
"A 32-year-old man is evaluated during a follow-up visit after passing his third calcium oxalate kidney stone in 4 years despite maintaining a high urine volume. He has no other medical problems. His only medication is potassium citrate, which was initiated after passing the most recent stone. He drinks 4 cups of coffee daily and typically eats meals at fast-food restaurants."
]
},
{
"type":"p",
"hlId":"f8786b",
"children":[
"Physical examination findings, including vital signs, are normal."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"0a500d",
"class":"cell text l",
"children":[
"24-Hour urine studies:"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"bd7a97",
"class":"cell text li",
"children":[
"Volume"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"82be25",
"class":"cell text l",
"children":[
"2600 mL"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"397dff",
"class":"cell text li",
"children":[
"pH"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"f884cc",
"class":"cell text l",
"children":[
"6.5"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"a9640c",
"class":"cell text li",
"children":[
"Calcium"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"9c5207",
"class":"cell text l",
"children":[
"295 mg (normal range, 50-300 mg)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"7e6003",
"class":"cell text li",
"children":[
"Citrate"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"eb2f9b",
"class":"cell text l",
"children":[
"850 mg (normal range, 100-300 mg)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"30f55d",
"class":"cell text li",
"children":[
"Oxalate"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"8b9679",
"class":"cell text l",
"children":[
"35 mg (normal range, 10-40 mg)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"67ec1b",
"class":"cell text li",
"children":[
"Uric acid"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"aef82e",
"class":"cell text l",
"children":[
"640 mg (normal range, 250-750 mg)"
]
}
]
}
]
}
]
}
]
},
{
"type":"p",
"hlId":"bd5972",
"children":[
"The patient is counseled to start a low sodium diet."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"1e31fb",
"children":[
"Which of the following is the most appropriate additional management?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Decrease calcium intake"
}
},
{
"letter":"B",
"text":{
"__html":"Decrease coffee intake"
}
},
{
"letter":"C",
"text":{
"__html":"Decrease oxalate intake"
}
},
{
"letter":"D",
"text":{
"__html":"Start allopurinol"
}
},
{
"letter":"E",
"text":{
"__html":"Start chlorthalidone"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"ac95af",
"children":[
"Thiazide diuretics decrease calcium excretion by up to 50% and can be used to manage recurrent calcium oxalate kidney stones."
]
},
{
"type":"keypoint",
"hlId":"278d12",
"children":[
"In patients with recurrent calcium oxalate kidney stones, urinary calcium excretion can be reduced by limiting sodium and protein intake."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"c68fcc",
"children":[
"The most appropriate additional management is to start chlorthalidone (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option E"
]
},
") to decrease urinary calcium excretion to prevent recurrent calcium oxalate stones. This patient's urinary calcium excretion is in the high-normal range. The threshold that defines high urinary calcium excretion and when to initiate a thiazide diuretic for prevention of calcium oxalate stones is unclear. However, the underlying principle is that the risk for stone formation is continuous with increasing amounts of calcium in the urine. Patients with ongoing stone formation despite dietary and fluid management should be considered for medical therapy with a thiazide diuretic to decrease urinary calcium excretion. Thiazide diuretics can decrease calcium excretion by up to 50% and reduce the recurrence of calcium oxalate stones. Chlorthalidone is the preferred agent because of its long half-life. Chlorthalidone increases calcium reabsorption in the kidney primarily by causing mild volume depletion, which increases sodium and calcium reabsorption in the proximal tubule. When hydrochlorothiazide is used, twice-daily dosing is recommended. In addition to chlorthalidone, urinary calcium excretion can also be reduced by limiting sodium and protein intake."
]
},
{
"type":"p",
"hlId":"cd9c80",
"children":[
"Decreasing calcium intake (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
") is not the most appropriate management. Because calcium complexes with oxalate in the gastrointestinal tract, decreasing calcium intake allows for increased oxalate absorption and increased risk for stone formation. Therefore, unless a person is on a high-calcium diet (>1500 mg/d), intake should not be limited."
]
},
{
"type":"p",
"hlId":"e18d77",
"children":[
"There is no evidence that excess coffee intake is associated with kidney stone disease, so reduction in coffee intake (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
") would not be expected to be beneficial."
]
},
{
"type":"p",
"hlId":"36cf18",
"children":[
"Except in patients with hyperoxaluria, limiting oxalate intake (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") has not been shown to decrease the incidence of stones, and thus the patient does not need to decrease intake."
]
},
{
"type":"p",
"hlId":"a8bb9a",
"children":[
"Because uric acid may serve as a nidus for stone formation, allopurinol (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
") has been used to reduce stone occurrence, especially in patients with high levels of uric acid in the urine, which is not present in this patient."
]
}
],
"relatedSection":"mk19_a_np_s10_5",
"objective":{
"__html":"Prevent recurrent calcium oxalate stone disease."
},
"references":[
[
"Zisman AL. Effectiveness of treatment modalities on kidney stone recurrence. Clin J Am Soc Nephrol. 2017;12:1699-1708. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28830863",
"target":"_blank"
},
"children":[
"PMID: 28830863"
]
},
" doi:10.2215/CJN.11201016"
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
"A":8,
"B":24,
"C":29,
"D":6,
"E":33
},
"hlIds":[
"e5248e",
"f8786b",
"a462a3",
"0a500d",
"d41d8c",
"bd7a97",
"82be25",
"397dff",
"f884cc",
"a9640c",
"9c5207",
"7e6003",
"eb2f9b",
"30f55d",
"8b9679",
"67ec1b",
"aef82e",
"bd5972",
"1e31fb",
"ac95af",
"278d12",
"c68fcc",
"cd9c80",
"e18d77",
"36cf18",
"a8bb9a"
]
}